Skip to main content

Advertisement

SpringerLink
Log in

Renovascular hypertension update

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Hypertension detected in patients with renovascular disease poses a major clinical challenge. The rapid expansion of noninvasive imaging, effective antihypertensive drug therapy, and endovascular interventional procedures combine to make optimal management a moving target. Renal arterial disease accelerates the development of hypertension associated with activation of multiple pressor systems and accelerated target organ injury. Younger individuals with fibromuscular lesions often respond well to renal revascularization with minor associated risks. Care must be taken in cases of complex vascular anomalies, such as renal artery aneurysms. Atherosclerotic renal artery stenosis is detected more commonly than ever before and affects more than 85% of patients referred for revascularization. Most are older patients with long-standing hypertension, diabetes, and pre-existing complications of vascular disease. The benefits of extensive workup and intervention in this group of patients are controversial. Antihypertensive drug therapy is most effectively achieved with drugs that block the reninangiotensin system, but most require multiple agents. Selection of patients for renal revascularization in this group is far more controversial than with fibromuscular disease. Several small trials failed to identify major benefits with renal artery angioplasty as compared to closely monitored drug therapy, although crossover rates from medical to interventional arms were high. The Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) seeks to randomly assign subjects with proven, high-grade renal artery lesions to optimal medical management with and without stenting. This important trial employs distal embolic protection to prevent deterioration of renal function. Understanding the optimal role for renal revascularization depends heavily upon the successful conduct of such trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Murphy TP, Soares G, Kim M: Increase in utilization of percutaneous renal artery interventions by Medicare beneficiaries 1996–2000. AJR Am J Roentgenol 2004, 183:561–568. This article is an mportant documentation of the spreading use of renal artery procedures, concurrent with declining use of vascular surgical procedures for renovascular disease. The large bulk of this increase was related to increased interventions from cardiologists.

    PubMed  Google Scholar 

  2. Garovic V, Textor SC: Renovascular hypertension: current concepts. Semin Nephrol 2005, 25:261–271.

    Article  PubMed  Google Scholar 

  3. Little MA, O’Brien E, Owens P, et al.: A longitudinal study of the yield and clinical utility of a specifically designed secondary hypertension investigation protocol. Ren Fail 2003, 25:709–717.

    Article  PubMed  Google Scholar 

  4. Surowiec SM, Sivamurthy N, Rhodes JM, et al.: Percutaneous therapy for renal artery fibromuscular dysplasia. Ann Vasc Surg 2003, 17:650–655.

    Article  PubMed  Google Scholar 

  5. Alhadad A, Mattiasson I, Ivancev K, et al.: Revasularisation of renal artery stenosis caused by fibromuscular dysplasia: effects on blood pressure during 7-year follow-up are infiuenced by duration of hypertension and branch artery stenosis. J Hum Hypertens 2005, 19:761–767. This article describes recent series of Fibromuscular Dysplasia patients treated effectively with percutaneous transluminal angioplasty (PTRA). The 7-year follow-up suggests excellent blood pressure reduction in many patients, although complete “cures” were unusual (24%). The authors indicate that long periods of known hypertension before intervention and branch vessel disease predicted a limited change in blood pressure after PTRA.

    Article  PubMed  CAS  Google Scholar 

  6. Carmo M, Bower TC, Mozes G, et al.: Surgical management of renal fibromuscular dysplasia: challenges in the endovascular era. Ann Vasc Surg 2005, 19:208–217.

    Article  PubMed  Google Scholar 

  7. Salifu MO, Haria DM, Badero O, et al.: Challenges in the diagnosis and management of renal artery stenosis. Curr Hypertens Rep 2005, 7:219–227.

    PubMed  Google Scholar 

  8. Hansen KJ, Edwards MS, Craven TE, et al.: Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg 2002, 36:443–451.

    Article  PubMed  Google Scholar 

  9. Edwards MS, Craven TE, Burke GL, et al.: Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study. Arch Intern Med 2005, 165:207–213.

    Article  PubMed  Google Scholar 

  10. Kalra PA, Guo H, Kausz AT, et al.: Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int 2005, 68:293–301. This article presents data from more than 1 million Medicare recipients followed over 2 years. It defines both the “incidence” of claims for renovascular disease and associated claims for cardiovascular morbidity over the subsequent years. These data restate the high associated cardiovascular risk of patients with atherosclerosis.

    Article  PubMed  Google Scholar 

  11. Buller CE, Nogareda JG, Ramanathan K, et al.: The profile of cardiac patients with renal artery stenosis. J Am Coll Cardiol 2004, 43:1606–1613.

    Article  PubMed  Google Scholar 

  12. Johansson M, Herlitz H, Jensen G, et al.: Increased cardiovascular mortality in hypertensive patients with renal artery stenosisfi Relation to sympathetic activation, renal function and treatment regimens. J Hypertens 1999, 17(12 Pt 1):1743–1750.

    Article  PubMed  CAS  Google Scholar 

  13. Gao SA, Johansson M, Rundqvist B, et al.: Reduced spontaneous baroreceptor sensitivity in patients with renovascular hypertension. J Hypertens 2002, 20:111–116.

    Article  PubMed  CAS  Google Scholar 

  14. Iantorno M, Pola R, Schinzari F, et al.: Association between altered circadian blood pressure profile and cardiac endorgan damage in patients with renovascular hypertension. Cardiology 2003, 100:114–119.

    Article  PubMed  Google Scholar 

  15. Grisk O, Rettig R: Interactions between the sympathetic nervous system and the kidneys in arterial hypertension. Cardiovasc Res 2004, 61:238–246.

    Article  PubMed  CAS  Google Scholar 

  16. Cervenka L, Horacek V, Vaneckova I, et al.: Essential role of AT1A receptor in the development of 2K1C hypertension. Hypertension 2002, 40:735–741.

    Article  PubMed  CAS  Google Scholar 

  17. Crowley SD, Gurley SB, Oliverio MI, et al.: Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest 2005, 115:1092–1099.

    Article  PubMed  CAS  Google Scholar 

  18. Lerman LO, Nath KA, Rodriguez-Porcel M, et al.: Increased oxidative stress in experimental renovascular hypertension. Hypertension 2001, 37(2 Pt 2):541–546.

    PubMed  CAS  Google Scholar 

  19. Jung O, Schreiber JG, Geiger H, et al.: gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation 2004, 109:1795–1801.

    Article  PubMed  CAS  Google Scholar 

  20. Welch WJ, Mendonca M, Aslam S, Wilcox CS: Roles of oxidative stress and AT1 receptors in renal hemodynamics and oxygenation in the postclipped 2K,1C kidney. Hypertension 2003, 41(3 Pt 2):692–696.

    Article  PubMed  CAS  Google Scholar 

  21. Parildar M, Parildar Z, Oran I, et al.: Nitric oxide and oxidative stress in atherosclerotic renovascular hypertension: effect of endovascular treatment. J Vasc Interv Radiol 2003, 14:887–892. This article describes a prospective study of 21 patients with unilateral atherosclerotic renovascular hypertension, who were studied before and after endovascular intervention. These studies demonstrated reduction of oxidative metabolites within days and weeks of the procedure, arguing that restoration of kidney blood flow aborts oxidative stress pathways. Activation of nitric oxide and superoxide dismutase increased temporarily, then fell after 6 weeks.

    PubMed  Google Scholar 

  22. Chade AR, Rodriguez-Porcel M, Grande JP, et al.: Distinct renal injury in early atherosclerosis and renovascular disease. Circulation 2002, 106:1165–1171.

    Article  PubMed  Google Scholar 

  23. Chade AR, Rodriguez-Porcel M, Grande JP, et al.: Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol 2003, 23:1295–1301.

    Article  PubMed  CAS  Google Scholar 

  24. Nordmann AJ, Woo K, Parkes R, Logan AG: Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? a meta-analysis of randomized controlled trials. Am J Med 2003, 114:44–50.

    Article  PubMed  Google Scholar 

  25. Ives NJ, Wheatley K, Stowe RL, et al.: Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. Nephrol Dial Transplant 2003, 18:298–304.

    Article  PubMed  Google Scholar 

  26. van Jaarsveld BC, Krijnen P, Pieterman H, et al.: The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosisfi Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000, 342:1007–1014.

    Article  PubMed  Google Scholar 

  27. Silva JA, Chan AW, White CJ, et al.: Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation 2005, 111:328–333. This article describes a recent study of circulating BNP levels in 27 patients with “refractory hypertension” subjected to endovascular renal artery stenting. The authors argue that elevated BNP levels (after correction for GFR) predicted a favorable blood pressure response. Whether these data will be confirmed remains to be seen.

    Article  PubMed  CAS  Google Scholar 

  28. Vasbinder GB, Nelemans PJ, Kessels AG, et al.: Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Int Med 2001, 135:401–411.

    PubMed  CAS  Google Scholar 

  29. Gandy SJ, Sudarshan TA, Sheppard DG, et al.: Dynamic MRI contrast enhancement of renal cortex: a functional assessment of renovascular disease in patients with renal artery stenosis. J Magn Reson Imaging 2003, 18:461–466.

    Article  PubMed  Google Scholar 

  30. Tan KT, van Beek EJ, Brown PW, et al.: Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. Clin Radiol 2002, 57:617–624.

    Article  PubMed  CAS  Google Scholar 

  31. Vasbinder GB, Nelemans PJ, Kessels AG, et al.: Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med 2004, 141:674–682.

    PubMed  Google Scholar 

  32. Napoli V, Pinto S, Bargellini I, et al.: Duplex ultrasonographic study of the renal arteries before and after renal artery stenting. Eur Radiol 2002, 12:796–803.

    Article  PubMed  CAS  Google Scholar 

  33. Radermacher J, Haller H: The right diagnostic work-up: investigating renal and renovascular disorders. J Hypertens Suppl 2003, 21:S19-S24.

    Article  PubMed  CAS  Google Scholar 

  34. Zeller T, Frank U, Muller C, et al.: Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation 2003, 108:2244–2249.

    Article  PubMed  Google Scholar 

  35. Textor SC: Pitfalls in imaging for renal artery stenosis. Ann Int Med 2004, 141:730–731.

    PubMed  Google Scholar 

  36. Giles TD, Sander GE: Beyond the usual strategies for blood pressure reduction: therapeutic considerations and combination therapies. J Clin Hypertens (Greenwich) 2001, 3:346–353.

    CAS  Google Scholar 

  37. Murphy TP, Cooper CJ, Dworkin LD, et al.: The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. J Vasc Interv Radiol 2005, 16:1295–1300. This article describes the design and rationale for the CORAL trial, started in 2005. The study undertakes to examine outcomes over 3 to 5 years of follow-up in more than 1000 patients with well-documented renal arterial lesions from atherosclerosis. After documentation of the lesions, patients are randomized to optimal medical therapy (including blood pressure, dyslipidemias, glucose tolerance, smoking cessation) with or without renovascular stenting using a distal protection device for those undergoing intervention.

    PubMed  Google Scholar 

  38. Losito A, Gaburri M, Errico R, et al.: Survival of patients with renovascular disease and ACE inhibition. Clin Nephrol 1999, 52:339–343.

    PubMed  CAS  Google Scholar 

  39. Kiykim AA, Boz M, Ozer C, et al.: Two episodes of anuria and acute pulmonary edema in a losartan-treated patient with solitary kidney. Heart Vessels 2004, 19:52–54.

    Article  PubMed  Google Scholar 

  40. Fernando D, Garasic J: Percutaneous intervention for renovascular disease: rationale and patient selection. Curr Opin Cardiol 2004, 19:582–588.

    Article  PubMed  Google Scholar 

  41. Butterly DW, Schwab SJ: Renal artery stenosis: the case for conservative management. Mayo Clin Proc 2000, 75:435–436.

    PubMed  CAS  Google Scholar 

  42. Plouin PF: Stable patients with atherosclerotic renal artery stenosis should be treated first with medical management. Am J Kidney Dis 2003, 42:851–857.

    Article  PubMed  Google Scholar 

  43. Schillinger M, Minar E, Ahmadi R: Treating renal artery stenosis. A statement pro endovascular therapy. Herz 2004, 29:68–75.

    Article  PubMed  Google Scholar 

  44. White CJ: Catheter-based therapy for atherosclerotic renal artery stenosis. Circulation 2006, 113:1464–1473. This well-balanced presentation for the enthusiastic position toward renal revascularization tends to overstate potential benefits from endovascular stenting, but does review the field well. The study recognizes the adverse potential of atheroembolic disease and ultimately concedes that intervention should be focused upon individuals with solid indications for revascularization procedures.

    Article  PubMed  Google Scholar 

  45. Ivanovic V, McKusick MA, Johnson CM 3rd, et al.: Renal artery stent placement: complications at a single tertiary care center. J Vasc Interv Radiol 2003, 14(2 Pt 1):217–225.

    PubMed  Google Scholar 

  46. Isles CG, Robertson S, Hill D: Management of renovascular disease: a review of renal artery stenting in ten studies. QJM 1999, 92:159–167.

    Article  PubMed  CAS  Google Scholar 

  47. Topol EJ, Yadav JS: Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000, 101:570–580.

    PubMed  CAS  Google Scholar 

  48. Garovic VD, Textor SC: Renovascular hypertension and ischemic nephropathy. Circulation 2005, 112:1362–1374.

    Article  PubMed  Google Scholar 

  49. Dorros G, Jaff M, Mathiak L, et al.: Multicenter Palmaz stent renal artery stenosis revascularization registry report: four-year follow-up of 1,058 successful patients. Catheter Cardiovasc Interv 2002, 55:182–188.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Division of Nephrology and Hypertension, 200 First Street, Mayo Clinic, 55905-0002, Rochester, MN, USA

    Stephen C. Textor MD

Authors
  1. Stephen C. Textor MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephen C. Textor MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Textor, S.C. Renovascular hypertension update. Current Science Inc 8, 521–527 (2006). https://doi.org/10.1007/s11906-006-0032-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-006-0032-9

Keywords

Search

Navigation